FDA Announces Public Advisory Committee Meeting on Pertussis Vaccine Efficacy Studies and Research Program

Summary

The Food and Drug Administration (FDA) is announcing a public advisory committee meeting of the Vaccines and Related Biological Products Advisory Committee to discuss the use of pertussis controlled human infection models in vaccine efficacy studies. The meeting will also cover a research program at the Center for Biologics Evaluation and Research.